Quinolone resistance in enterotoxigenic Escherichia coli causing diarrhea in travelers to India in comparison with other geographical areas
- Jordi Vila,
- Martha Vargas,
- ,
- Manuel Corachan,
- M. Teresa Jimenez De Anta,
- Joaquim Gascon
- Hospital Clínic – Universitat de Barcelona,
Research Output:
Contribution to journal
Article
Peer-reviewOpen access
Publication Information
Output type
Research Output:
Contribution to journal
Article
Peer-reviewOriginal language
EnglishPages from-to (Number of pages)
Pages 1731-1733 (3 pages)Journal (Volume, Issue Number)
Antimicrobial Agents and Chemotherapy (Volume 44, Issue 6)Publication milestones
- Published - 2000
Publication status
Published - 2000
ISSN
0066-4804Publication IDs
- Scopus: 0034036550
- PubMed: 10817742
Abstract
Enterotoxigenic Escherichia coli isolates were identified as a cause of traveler's diarrhea in 82 of 520 (16%) patients and tested for resistance to seven antimicrobial agents. Thirty patients (36%) needed antimicrobial therapy: 17 (56%) for persistence of symptoms and 13 (44%) for severity of symptoms. Ampicillin, tetracycline, and trimethoprim-sulfamethoxazole resistance was high. Chloramphenicol showed moderate activity, and amoxicillin plus clavulanic acid, nalidixic acid, and ciprofloxacin showed very good activity. Five nalidixic acid-resistant strains were isolated, four from patients visiting India.
Publication metrics
Metrics
PlumX, opens in new tab
Social media
26
Citations
58
Captures
44
Sustainable Development Goals
- SDG 3 Good Health and Well
